Menu Search
Equities

ProKidney Corp

PROK:NAQ

ProKidney Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.69
  • Today's Change-0.05 / -2.87%
  • Shares traded370.34k
  • 1 Year change-5.59%
  • Beta1.3247
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at ProKidney Corp fell by 429.60m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 90.07m for operations while cash used for investing totalled 329.98m.
Cash flow per share-1.62
Price/Cash flow per share--
Book value per share-3.36
Tangible book value per share-3.36
More ▼

Balance sheet in USDView more

ProKidney Corp uses little debt in its capital structure as supported by a debt to capital ratio of 0.03%.
Current ratio17.09
Quick ratio--
Total debt/total equity--
Total debt/total capital0.0003
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.